{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:16:22Z","timestamp":1793722582312,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7244490"],"award-info":[{"award-number":["7244490"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204921"],"award-info":[{"award-number":["82204921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disease whose cause and molecular mechanism remain unclear. Dingzhen pill (DZP), a water extract from crude herbs, is thought to possibly play a neuroprotective role in PD. However, the underlying pharmacological mechanisms of the DZP and its impact on the potential pathways against PD have not been elucidated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>The aim of this study was to explore the effect and molecular mechanism of DZP treatment on PD by quantitative proteomic and metabolomic analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The effect of DZP on the behavior of movement disorders\u00a0in a mouse model of MPTP-induced was first evaluated. Secondary metabolomics for TCM resolved the components of DZP and its metabolites distributed in the serum of PD mice. Proteomics was used to resolve the effects of DZP on proteins in brain tissue in mice with PD. Network pharmacology and molecular docking analysis were used to screen and validate the binding relationships of components and targets. Immunofluorescence and western blot analysis verified the pathway affected by DZP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our study showed that DZP improved the movement disorder of PD mice and promoted the recovery of dopaminergic neurons in substantia nigra. Secondary metabolomics showed that 460 kinds of secondary metabolites existed in serum of PD mice after DZP treatment. Proteomics analysis showed that DZP affected the expression of 9393 proteins, 87 of which were up-regulated and 120 down-regulated. Through target prediction and molecular docking, a total of 8 compounds were found to interact with 8 pathological PD targets, playing a significant role in neuronal protection. In addition, DZP inhibits neuronal ferroptosis and neuroinflammation by inhibiting the cGAS-STING pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study is helpful to understand the molecular mechanism of the multi-component, multi-target neuroprotective effect of DZ, and may contribute to the development of DZP as a new therapeutic strategy for clinical application in PD.  <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13020-025-01135-9","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:30:52Z","timestamp":1750062652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dingzhen pills inhibit neuronal ferroptosis and neuroinflammation by inhibiting the cGAS-STING pathway for Parkinson\u2019s disease mice"],"prefix":"10.1186","volume":"20","author":[{"given":"Gaoshuang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"1135_CR1","unstructured":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 2019, 18(5): 459\u201380."},{"issue":"s1","key":"1135_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, et al. The emerging evidence of the Parkinson pandemic. J Parkinson\u2019s Dis. 2018;8(s1):S3-s8.","journal-title":"J Parkinson\u2019s Dis"},{"issue":"Suppl 1","key":"1135_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S. The clinical symptoms of Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):318\u201324.","journal-title":"J Neurochem"},{"issue":"10423","key":"1135_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, et al. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"issue":"16","key":"1135_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670\u201383.","journal-title":"JAMA"},{"issue":"7","key":"1135_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","volume":"45","author":"B Turgutalp","year":"2024","unstructured":"Turgutalp B, Kizil C. Multi-target drugs for Alzheimer\u2019s disease. Trends Pharmacol Sci. 2024;45(7):628\u201338.","journal-title":"Trends Pharmacol Sci"},{"key":"1135_CR7","doi-asserted-by":"publisher","first-page":"879459","DOI":"10.3389\/fphar.2022.879459","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu X. Chinese herbal medicine in the treatment of depression in Parkinson\u2019s disease: from molecules to systems. Front Pharmacol. 2022;13:879459.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1135_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1080\/13880209.2020.1817103","volume":"58","author":"P Yi","year":"2020","unstructured":"Yi P, Zhang Z, Huang S, et al. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer\u2019s disease. Pharm Biol. 2020;58(1):932\u201343.","journal-title":"Pharm Biol"},{"key":"1135_CR9","unstructured":"Jiang HP, Fang MQ. Dingzhen Decoction combined with levodopa\/benserazide in Parkinson's disease: Efficacy and mechanism exploration in liver-kidney yin deficiency pattern. J Sichuan Tradit Chin Med. 2019; 37(10): 125-8."},{"key":"1135_CR10","first-page":"728","volume":"05","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liang W, Luo X. Clinical controlled study on the treatment of Parkinson\u2019s disease with Traditional Chinese Medicine Dingzhen Decoction. Liaoning J Tradit Chin Med. 2008;05:728\u20139.","journal-title":"Liaoning J Tradit Chin Med"},{"issue":"14","key":"1135_CR11","first-page":"103","volume":"34","author":"H Kang","year":"2022","unstructured":"Kang H. The efficacy of Dingzhen pills combined with Pramipexole in the treatment of Parkinson\u2019s disease patients. Med J Chin People\u2019s Health. 2022;34(14):103\u20136.","journal-title":"Med J Chin People\u2019s Health"},{"issue":"03","key":"1135_CR12","first-page":"604","volume":"42","author":"Q Huo","year":"2020","unstructured":"Huo Q, Tan F, Lin D, et al. The effects of Dingzhen pills on neurotransmitters and oxidative stress in dopaminergic neurons of substantia nigra in a rat model of Parkinson\u2019s disease. Chin Tradit Pat Med. 2020;42(03):604\u201310.","journal-title":"Chin Tradit Pat Med"},{"issue":"7","key":"1135_CR13","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.7150\/thno.95908","volume":"14","author":"J Cao","year":"2024","unstructured":"Cao J, Li C, Cui Z, et al. Spatial transcriptomics: a powerful tool in disease understanding and drug discovery. Theranostics. 2024;14(7):2946\u201368.","journal-title":"Theranostics"},{"issue":"5","key":"1135_CR14","doi-asserted-by":"publisher","first-page":"156553","DOI":"10.1016\/j.phymed.2025.156553","volume":"140","author":"T Lei","year":"2025","unstructured":"Lei T, Fu GS, Xue X, et al. Tianma Gouteng Decoction improve neuronal synaptic plasticity and oligodendrocyte apoptosis in Parkinson\u2019s disease mice. Phytomedicine. 2025. https:\/\/doi.org\/10.1016\/j.phymed.2025.156553.","journal-title":"Phytomedicine"},{"key":"1135_CR15","doi-asserted-by":"publisher","first-page":"115021","DOI":"10.1016\/j.biopha.2023.115021","volume":"165","author":"B Pan","year":"2023","unstructured":"Pan B, Niu B, He Y, et al. Integrative multilevel exploration of the mechanism by which Er-Zhi-Wan alleviates the Parkinson\u2019s disease (PD)-like phenotype in the MPTP-induced PD mouse model. Biomed Pharmacother. 2023;165:115021.","journal-title":"Biomed Pharmacother"},{"key":"1135_CR16","doi-asserted-by":"publisher","first-page":"154357","DOI":"10.1016\/j.phymed.2022.154357","volume":"105","author":"Y Wu","year":"2022","unstructured":"Wu Y, Liu H, Wang Y, et al. DiHuangYin decoction protects dopaminergic neurons in a Parkinson\u2019s disease model by alleviating peripheral inflammation. Phytomedicine. 2022;105:154357.","journal-title":"Phytomedicine"},{"issue":"Pt A","key":"1135_CR17","doi-asserted-by":"publisher","first-page":"116893","DOI":"10.1016\/j.jep.2023.116893","volume":"318","author":"J Hu","year":"2024","unstructured":"Hu J, Li P, Zhao H, et al. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson\u2019s disease with Buyang Huanwu decoction. J Ethnopharmacol. 2024;318(Pt A):116893.","journal-title":"J Ethnopharmacol"},{"key":"1135_CR18","doi-asserted-by":"publisher","first-page":"112706","DOI":"10.1016\/j.biopha.2022.112706","volume":"148","author":"S Dongjie","year":"2022","unstructured":"Dongjie S, Rajendran RS, Xia Q, et al. Neuroprotective effects of Tongtian oral liquid, a Traditional Chinese Medicine in the Parkinson\u2019s disease-induced zebrafish model. Biomed Pharmacother. 2022;148:112706.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1135_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.4103\/NRR.NRR-D-24-00110","volume":"20","author":"M Locatelli","year":"2025","unstructured":"Locatelli M, Farina C. Role of copper in central nervous system physiology and pathology. Neural Regen Res. 2025;20(4):1058\u201368.","journal-title":"Neural Regen Res"},{"key":"1135_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fphar.2012.00169","volume":"3","author":"T SKJ\u00f8RRINGE","year":"2012","unstructured":"SKJ\u00f8RRINGE T, M\u00f8LLER LB, MOOS T. Impairment of interrelated iron-and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. Front Pharmacol. 2012;3:169.","journal-title":"Front Pharmacol"},{"key":"1135_CR21","doi-asserted-by":"publisher","first-page":"115496","DOI":"10.1016\/j.bcp.2023.115496","volume":"210","author":"SS KHAN","year":"2023","unstructured":"KHAN SS, JANRAO S, SRIVASTAVA S, et al. GSK-3\u03b2: an exuberating neuroinflammatory mediator in Parkinson\u2019s disease. Biochem Pharmacol. 2023;210:115496.","journal-title":"Biochem Pharmacol"},{"key":"1135_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.freeradbiomed.2024.01.045","volume":"213","author":"J Gui","year":"2024","unstructured":"Gui J, Wang L, Liu J, et al. Ambient particulate matter exposure induces ferroptosis in hippocampal cells through the GSK3B\/Nrf2\/GPX4 pathway. Free Radical Biol Med. 2024;213:359\u201370.","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"1135_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"ZL Wang","year":"2022","unstructured":"Wang ZL, Yuan L, Li W, et al. Ferroptosis in Parkinson\u2019s disease: glia-neuron crosstalk. Trends Mol Med. 2022;28(4):258\u201369.","journal-title":"Trends Mol Med"},{"key":"1135_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2024.04.002","volume":"218","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li G, Chen H, et al. Targeting NKA\u03b11 to treat Parkinson\u2019s disease through inhibition of mitophagy-dependent ferroptosis. Free Radical Biol Med. 2024;218:190\u2013204.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"1135_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12906-023-03967-0","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, Zhang J, Jiang L, et al. Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson\u2019s disease via inhibiting oxidative stress and ferroptosis. BMC Complement Med Ther. 2023;23(1):218.","journal-title":"BMC Complement Med Ther"},{"key":"1135_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.freeradbiomed.2024.06.020","volume":"222","author":"Z Yao","year":"2024","unstructured":"Yao Z, Jia F, Wang S, et al. The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson\u2019s disease. Free Radical Biol Med. 2024;222:386\u201396.","journal-title":"Free Radical Biol Med"},{"issue":"6","key":"1135_CR27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00401-019-01993-2","volume":"137","author":"D Hu","year":"2019","unstructured":"Hu D, Sun X, Liao X, et al. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol. 2019;137(6):939\u201360.","journal-title":"Acta Neuropathol"},{"key":"1135_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuint.2014.12.012","volume":"88","author":"J Ruszkiewicz","year":"2015","unstructured":"Ruszkiewicz J, Albrecht J. Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders. Neurochem Int. 2015;88:66\u201372.","journal-title":"Neurochem Int"},{"issue":"1","key":"1135_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13024-023-00672-x","volume":"18","author":"YG Huang","year":"2023","unstructured":"Huang YG, Liu BY, Sinha SC, et al. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. Mol Neurodegener. 2023. https:\/\/doi.org\/10.1186\/s13024-023-00672-x.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"1135_CR30","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","volume":"30","author":"SY Jiang","year":"2023","unstructured":"Jiang SY, Tian T, Yao H, et al. The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson\u2019s disease via LCN2-dependent astrocyte senescence. Cell Death Differ. 2023;30(10):2280\u201392.","journal-title":"Cell Death Differ"},{"issue":"7","key":"1135_CR31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/cns.14157","volume":"29","author":"CM Ma","year":"2023","unstructured":"Ma CM, Liu Y, Li S, et al. Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson\u2019s disease. Cns Neurosci Ther. 2023;29(7):2018\u201335.","journal-title":"Cns Neurosci Ther"},{"issue":"8","key":"1135_CR32","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","volume":"28","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang BW, Zhang CY, et al. The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson\u2019s disease. Cell Death Differ. 2021;28(8):2517\u201335.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1135_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12951-024-02587-1","volume":"22","author":"T Lei","year":"2024","unstructured":"Lei T, Li CF, Liu Y, et al. Microfluidics-enabled mesenchymal stem cell derived neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson\u2019s Disease. J Nanobiotechnol. 2024. https:\/\/doi.org\/10.1186\/s12951-024-02587-1.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"1135_CR34","doi-asserted-by":"publisher","first-page":"e22949","DOI":"10.1002\/jbt.22949","volume":"36","author":"Q Wu","year":"2022","unstructured":"Wu Q, Wang M, Chen W, et al. Daidzein exerts neuroprotective activity against MPTP-induced Parkinson\u2019s disease in experimental mice and lipopolysaccharide-induced BV2 microglial cells. J Biochem Mol Toxicol. 2022;36(2):e22949.","journal-title":"J Biochem Mol Toxicol"},{"issue":"12","key":"1135_CR35","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s12272-019-01191-4","volume":"42","author":"YH Ko","year":"2019","unstructured":"Ko YH, Kwon SH, Kim SK, et al. Protective effects of 6,7,4\u2019-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells. Arch Pharmacal Res. 2019;42(12):1081\u201391.","journal-title":"Arch Pharmacal Res"},{"issue":"4","key":"1135_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4062\/biomolther.2018.211","volume":"27","author":"YH Ko","year":"2019","unstructured":"Ko YH, Kim SK, Kwon SH, et al. 7,8,4\u2019-Trihydroxyisoflavone, a metabolized product of daidzein, attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y Cells. Biomol Ther. 2019;27(4):363\u201372.","journal-title":"Biomol Ther"},{"issue":"7","key":"1135_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1871527319666200812224457","volume":"19","author":"W Zahra","year":"2020","unstructured":"Zahra W, Rai SN, Birla H, et al. Neuroprotection of rotenone-induced Parkinsonism by Ursolic acid in PD mouse model. CNS Neurol Disord. 2020;19(7):527\u201340.","journal-title":"CNS Neurol Disord"},{"issue":"4","key":"1135_CR38","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41401-022-00988-2","volume":"44","author":"Y Bang","year":"2023","unstructured":"Bang Y, Kwon Y, Kim M, et al. Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson\u2019s disease mice model. Acta Pharmacol Sin. 2023;44(4):752\u201365.","journal-title":"Acta Pharmacol Sin"},{"key":"1135_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.brainresbull.2020.03.003","volume":"160","author":"V Peshattiwar","year":"2020","unstructured":"Peshattiwar V, Muke S, Kaikini A, et al. Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson\u2019s disease\u2014emphasizing the role of mitochondrial biogenesis. Brain Res Bull. 2020;160:150\u201361.","journal-title":"Brain Res Bull"},{"key":"1135_CR40","doi-asserted-by":"publisher","first-page":"112182","DOI":"10.1016\/j.jep.2019.112182","volume":"245","author":"M Zheng","year":"2019","unstructured":"Zheng M, Liu C, Fan Y, et al. Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP\/PKA\/CREB signaling pathway. J Ethnopharmacol. 2019;245:112182.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1135_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/sj.bjp.0706732","volume":"148","author":"HQ Liu","year":"2006","unstructured":"Liu HQ, Zhang WY, Luo XT, et al. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease by activation of adenosine A1 receptor. Br J Pharmacol. 2006;148(3):314\u201325.","journal-title":"Br J Pharmacol"},{"key":"1135_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.neuropharm.2017.01.009","volume":"116","author":"M Zheng","year":"2017","unstructured":"Zheng M, Liu C, Fan Y, et al. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology. 2017;116:412\u201320.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1135_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jep.2010.06.009","volume":"131","author":"BY Cao","year":"2010","unstructured":"Cao BY, Yang YP, Luo WF, et al. Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway. J Ethnopharmacol. 2010;131(1):122\u20139.","journal-title":"J Ethnopharmacol"},{"key":"1135_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fnins.2020.00398","volume":"14","author":"TR Yamasaki","year":"2020","unstructured":"Yamasaki TR, Ono K, Ho L, et al. Gut microbiome-modified polyphenolic compounds inhibit \u03b1-synuclein seeding and spreading in \u03b1-synucleinopathies. Front Neurosci. 2020;14:398.","journal-title":"Front Neurosci"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01135-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T10:02:44Z","timestamp":1750068164000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01135-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01135-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Experimental Animal Welfare and Ethics Committee of the Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences (Approval number: 202312). The study was conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}